Agilent Technologies Net Income 2010-2025 | A
Agilent Technologies annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Agilent Technologies net income for the quarter ending April 30, 2025 was $215M, a 30.19% decline year-over-year.
- Agilent Technologies net income for the twelve months ending April 30, 2025 was $1.166B, a 6.12% decline year-over-year.
- Agilent Technologies annual net income for 2024 was $1.289B, a 3.95% increase from 2023.
- Agilent Technologies annual net income for 2023 was $1.24B, a 1.12% decline from 2022.
- Agilent Technologies annual net income for 2022 was $1.254B, a 3.64% increase from 2021.
| Agilent Technologies Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $1,289 |
| 2023 | $1,240 |
| 2022 | $1,254 |
| 2021 | $1,210 |
| 2020 | $719 |
| 2019 | $1,071 |
| 2018 | $316 |
| 2017 | $684 |
| 2016 | $462 |
| 2015 | $401 |
| 2014 | $549 |
| 2013 | $734 |
| 2012 | $1,153 |
| 2011 | $1,012 |
| 2010 | $684 |
| 2009 | $-31 |
| Agilent Technologies Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-04-30 | $215 |
| 2025-01-31 | $318 |
| 2024-10-31 | $351 |
| 2024-07-31 | $282 |
| 2024-04-30 | $308 |
| 2024-01-31 | $348 |
| 2023-10-31 | $475 |
| 2023-07-31 | $111 |
| 2023-04-30 | $302 |
| 2023-01-31 | $352 |
| 2022-10-31 | $368 |
| 2022-07-31 | $329 |
| 2022-04-30 | $274 |
| 2022-01-31 | $283 |
| 2021-10-31 | $442 |
| 2021-07-31 | $264 |
| 2021-04-30 | $216 |
| 2021-01-31 | $288 |
| 2020-10-31 | $222 |
| 2020-07-31 | $199 |
| 2020-04-30 | $101 |
| 2020-01-31 | $197 |
| 2019-10-31 | $194 |
| 2019-07-31 | $191 |
| 2019-04-30 | $182 |
| 2019-01-31 | $504 |
| 2018-10-31 | $195 |
| 2018-07-31 | $236 |
| 2018-04-30 | $205 |
| 2018-01-31 | $-320 |
| 2017-10-31 | $177 |
| 2017-07-31 | $175 |
| 2017-04-30 | $164 |
| 2017-01-31 | $168 |
| 2016-10-31 | $126 |
| 2016-07-31 | $124 |
| 2016-04-30 | $91 |
| 2016-01-31 | $121 |
| 2015-10-31 | $140 |
| 2015-07-31 | $111 |
| 2015-04-30 | $87 |
| 2015-01-31 | $63 |
| 2014-10-31 | $16 |
| 2014-07-31 | $147 |
| 2014-04-30 | $139 |
| 2014-01-31 | $195 |
| 2013-10-31 | $211 |
| 2013-07-31 | $168 |
| 2013-04-30 | $166 |
| 2013-01-31 | $179 |
| 2012-10-31 | $425 |
| 2012-07-31 | $243 |
| 2012-04-30 | $255 |
| 2012-01-31 | $230 |
| 2011-10-31 | $289 |
| 2011-07-31 | $330 |
| 2011-04-30 | $200 |
| 2011-01-31 | $193 |
| 2010-10-31 | $292 |
| 2010-07-31 | $205 |
| 2010-04-30 | $108 |
| 2010-01-31 | $79 |
| 2009-10-31 | $25 |
| 2009-07-31 | $-19 |
| 2009-04-30 | $-101 |
| 2009-01-31 | $64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.366B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.034B | 28.02 |
| Boston Scientific (BSX) | United States | $152.131B | 38.08 |
| Stryker (SYK) | United States | $146.225B | 30.58 |
| EssilorLuxottica (ESLOY) | France | $128.281B | 0.00 |
| Medtronic (MDT) | Ireland | $111.581B | 15.82 |
| Haleon (HLN) | United Kingdom | $50.069B | 28.51 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.244B | 0.00 |
| ResMed (RMD) | United States | $36.611B | 27.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.762B | 15.55 |
| Terumo (TRUMY) | Japan | $26.576B | 34.52 |
| Insulet (PODD) | United States | $22.320B | 87.61 |
| Koninklijke Philips (PHG) | Netherlands | $21.929B | 15.76 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.186B | 11.68 |
| Baxter (BAX) | United States | $15.472B | 11.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.449B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.968B | 20.77 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 14.02 |
| Prestige Consumer Healthcare (PBH) | United States | $4.181B | 18.68 |
| Perrigo (PRGO) | Ireland | $3.570B | 9.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.382B | 15.40 |
| ICU Medical (ICUI) | United States | $3.271B | 24.12 |
| Envista Holdings (NVST) | United States | $3.166B | 26.31 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.022B | 13.91 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.12 |
| AtriCure (ATRC) | United States | $1.726B | 0.00 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.080B | 24.29 |
| Neogen (NEOG) | United States | $1.066B | 13.64 |
| Kestra Medical Technologies (KMTS) | United States | $1.025B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.38 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.633B | 0.00 |
| Evolus (EOLS) | United States | $0.628B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.602B | 0.00 |
| Owens & Minor (OMI) | United States | $0.588B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Valneva SE (VALN) | France | $0.525B | 0.00 |
| Surmodics (SRDX) | United States | $0.426B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.391B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.345B | 12.68 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 54.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.97 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.254B | 11.54 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| Biote (BTMD) | United States | $0.201B | 5.65 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.195B | 51.55 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| Agape ATP (ATPC) | $0.073B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.036B | 48.57 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |